Allied Investment Advisors LLC Acquires 1,111 Shares of The Procter & Gamble Company (NYSE:PG)

Allied Investment Advisors LLC raised its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.8% in the 3rd quarter, Holdings Channel reports. The firm owned 61,562 shares of the company’s stock after acquiring an additional 1,111 shares during the period. Procter & Gamble makes up 2.1% of Allied Investment Advisors LLC’s investment portfolio, making the stock its 23rd largest holding. Allied Investment Advisors LLC’s holdings in Procter & Gamble were worth $10,662,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in PG. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the second quarter valued at $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth about $29,000. Ruedi Wealth Management Inc. raised its position in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after buying an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at about $34,000. Finally, Transcendent Capital Group LLC purchased a new position in Procter & Gamble in the fourth quarter worth about $31,000. 65.77% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Jon R. Moeller sold 7,007 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the transaction, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at $46,203,373.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the completion of the transaction, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 383,194 shares of company stock valued at $65,140,718. Insiders own 0.17% of the company’s stock.

Procter & Gamble Stock Down 0.7 %

NYSE PG traded down $1.24 on Friday, hitting $168.88. The stock had a trading volume of 6,003,668 shares, compared to its average volume of 6,670,893. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The stock has a market cap of $398.58 billion, a price-to-earnings ratio of 27.59, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $177.94. The business’s fifty day moving average price is $171.15 and its 200 day moving average price is $166.48.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.03. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the company posted $1.37 EPS. Equities research analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date was Friday, July 19th. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Wall Street Analyst Weigh In

PG has been the subject of several analyst reports. BNP Paribas began coverage on Procter & Gamble in a research note on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective for the company. Piper Sandler assumed coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Evercore ISI raised their target price on shares of Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Finally, Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. Nine equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $175.89.

Check Out Our Latest Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.